<?xml version="1.0" encoding="UTF-8"?>
<p>Compound 
 <bold>181</bold> (50 mg·kg
 <sup>−1</sup>·day
 <sup>−1</sup>) was orally administered to CD-1 mice with parasite clearance of 44.6 ± 5.6%. Although this is the first in vivo efficacy reported, a follow-up dose-response study (25–100 mg·kg
 <sup>−1</sup>·day
 <sup>−1</sup>) showed poor parasite clearance at other concentrations, and no clear dose-response was observed.
</p>
